265 related articles for article (PubMed ID: 20943659)
21. Biophysical characterization of Ca
Kim I; Lee KO; Yun YJ; Jeong JY; Kim EH; Cheong H; Ryu KS; Kim NK; Suh JY
Biochem Biophys Res Commun; 2017 Jan; 483(1):332-338. PubMed ID: 28017722
[TBL] [Abstract][Full Text] [Related]
22. S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains.
Leclerc E; Fritz G; Weibel M; Heizmann CW; Galichet A
J Biol Chem; 2007 Oct; 282(43):31317-31. PubMed ID: 17726019
[TBL] [Abstract][Full Text] [Related]
23. Distinct roles of heterogeneous nuclear ribonuclear protein K and microRNA-16 in cyclooxygenase-2 RNA stability induced by S100b, a ligand of the receptor for advanced glycation end products.
Shanmugam N; Reddy MA; Natarajan R
J Biol Chem; 2008 Dec; 283(52):36221-33. PubMed ID: 18854308
[TBL] [Abstract][Full Text] [Related]
24. The effects of CapZ peptide (TRTK-12) binding to S100B-Ca2+ as examined by NMR and X-ray crystallography.
Charpentier TH; Thompson LE; Liriano MA; Varney KM; Wilder PT; Pozharski E; Toth EA; Weber DJ
J Mol Biol; 2010 Mar; 396(5):1227-43. PubMed ID: 20053360
[TBL] [Abstract][Full Text] [Related]
25. Molecular Characteristics of RAGE and Advances in Small-Molecule Inhibitors.
Kim HJ; Jeong MS; Jang SB
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34199060
[TBL] [Abstract][Full Text] [Related]
26. A model of full-length RAGE in complex with S100B.
Moysa A; Steczkiewicz K; Niedzialek D; Hammerschmid D; Zhukova L; Sobott F; Dadlez M
Structure; 2021 Sep; 29(9):989-1002.e6. PubMed ID: 33887170
[TBL] [Abstract][Full Text] [Related]
27. Human eosinophils express RAGE, produce RAGE ligands, exhibit PKC-delta phosphorylation and enhanced viability in response to the RAGE ligand, S100B.
Curran CS; Bertics PJ
Int Immunol; 2011 Dec; 23(12):713-28. PubMed ID: 22025532
[TBL] [Abstract][Full Text] [Related]
28. Genetically-determined hyperfunction of the S100B/RAGE axis is a risk factor for aspergillosis in stem cell transplant recipients.
Cunha C; Giovannini G; Pierini A; Bell AS; Sorci G; Riuzzi F; Donato R; Rodrigues F; Velardi A; Aversa F; Romani L; Carvalho A
PLoS One; 2011; 6(11):e27962. PubMed ID: 22114731
[TBL] [Abstract][Full Text] [Related]
29. Amphoterin stimulates myogenesis and counteracts the antimyogenic factors basic fibroblast growth factor and S100B via RAGE binding.
Sorci G; Riuzzi F; Arcuri C; Giambanco I; Donato R
Mol Cell Biol; 2004 Jun; 24(11):4880-94. PubMed ID: 15143181
[TBL] [Abstract][Full Text] [Related]
30. Prothrombin is a binding partner of the human receptor of advanced glycation end products.
Degani G; Altomare A; Digiovanni S; Arosio B; Fritz G; Raucci A; Aldini G; Popolo L
J Biol Chem; 2020 Aug; 295(35):12498-12511. PubMed ID: 32665403
[TBL] [Abstract][Full Text] [Related]
31. Blocking the Interactions between Calcium-Bound S100A12 Protein and the V Domain of RAGE Using Tranilast.
Chiou JW; Fu B; Chou RH; Yu C
PLoS One; 2016; 11(9):e0162000. PubMed ID: 27598566
[TBL] [Abstract][Full Text] [Related]
32. Small molecules bound to unique sites in the target protein binding cleft of calcium-bound S100B as characterized by nuclear magnetic resonance and X-ray crystallography.
Charpentier TH; Wilder PT; Liriano MA; Varney KM; Zhong S; Coop A; Pozharski E; MacKerell AD; Toth EA; Weber DJ
Biochemistry; 2009 Jul; 48(26):6202-12. PubMed ID: 19469484
[TBL] [Abstract][Full Text] [Related]
33. [Not Available].
Kumar V; Sulaj A; Fleming T; Nawroth PP
Exp Clin Endocrinol Diabetes; 2018 Mar; 126(3):141-147. PubMed ID: 28926869
[TBL] [Abstract][Full Text] [Related]
34. Divergent pathways of gene expression are activated by the RAGE ligands S100b and AGE-BSA.
Valencia JV; Mone M; Zhang J; Weetall M; Buxton FP; Hughes TE
Diabetes; 2004 Mar; 53(3):743-51. PubMed ID: 14988260
[TBL] [Abstract][Full Text] [Related]
35. Glycation reaction and the role of the receptor for advanced glycation end-products in immunity and social behavior.
Leerach N; Harashima A; Munesue S; Kimura K; Oshima Y; Goto H; Yamamoto H; Higashida H; Yamamoto Y
Glycoconj J; 2021 Jun; 38(3):303-310. PubMed ID: 33108607
[TBL] [Abstract][Full Text] [Related]
36. Carboxylated N-glycans on RAGE promote S100A12 binding and signaling.
Srikrishna G; Nayak J; Weigle B; Temme A; Foell D; Hazelwood L; Olsson A; Volkmann N; Hanein D; Freeze HH
J Cell Biochem; 2010 Jun; 110(3):645-59. PubMed ID: 20512925
[TBL] [Abstract][Full Text] [Related]
37. Perspectives on RAGE signaling and its role in cardiovascular disease.
Cohen MM
Am J Med Genet A; 2013 Nov; 161A(11):2750-5. PubMed ID: 24123885
[TBL] [Abstract][Full Text] [Related]
38. Key role of Src kinase in S100B-induced activation of the receptor for advanced glycation end products in vascular smooth muscle cells.
Reddy MA; Li SL; Sahar S; Kim YS; Xu ZG; Lanting L; Natarajan R
J Biol Chem; 2006 May; 281(19):13685-13693. PubMed ID: 16551628
[TBL] [Abstract][Full Text] [Related]
39. CD166/ALCAM mediates proinflammatory effects of S100B in delayed type hypersensitivity.
von Bauer R; Oikonomou D; Sulaj A; Mohammed S; Hotz-Wagenblatt A; Gröne HJ; Arnold B; Falk C; Luethje D; Erhardt A; Stern DM; Bierhaus A; Nawroth PP
J Immunol; 2013 Jul; 191(1):369-77. PubMed ID: 23729438
[TBL] [Abstract][Full Text] [Related]
40. Targeting receptors of advanced glycation end products (RAGE): Preventing diabetes induced cancer and diabetic complications.
Chhipa AS; Borse SP; Baksi R; Lalotra S; Nivsarkar M
Pathol Res Pract; 2019 Nov; 215(11):152643. PubMed ID: 31564569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
